The Clorox Company (NYSE:CLX) Receives Average Rating of “Reduce” from Analysts

Shares of The Clorox Company (NYSE:CLXGet Free Report) have been given an average rating of “Reduce” by the sixteen ratings firms that are presently covering the company, MarketBeat reports. Four equities research analysts have rated the stock with a sell rating and twelve have assigned a hold rating to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $148.63.

CLX has been the subject of a number of recent research reports. Barclays dropped their target price on Clorox from $148.00 to $136.00 and set an “underweight” rating for the company in a report on Wednesday, April 10th. Morgan Stanley reiterated an “equal weight” rating and issued a $160.00 target price on shares of Clorox in a report on Tuesday, March 26th. Deutsche Bank Aktiengesellschaft dropped their target price on Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. Citigroup dropped their target price on Clorox from $165.00 to $155.00 and set a “neutral” rating for the company in a report on Tuesday, April 16th. Finally, DA Davidson reiterated a “neutral” rating and issued a $162.00 target price on shares of Clorox in a report on Wednesday, April 17th.

View Our Latest Report on Clorox

Clorox Stock Performance

NYSE:CLX opened at $146.48 on Friday. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. Clorox has a 12-month low of $114.68 and a 12-month high of $178.21. The stock has a 50-day moving average price of $149.39 and a 200 day moving average price of $142.47. The stock has a market capitalization of $18.18 billion, a P/E ratio of 232.51, a P/E/G ratio of 2.34 and a beta of 0.43.

Clorox (NYSE:CLXGet Free Report) last released its quarterly earnings results on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.08 by $1.08. The business had revenue of $1.99 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The firm’s revenue for the quarter was up 16.0% compared to the same quarter last year. During the same quarter last year, the business posted $0.98 EPS. Equities research analysts forecast that Clorox will post 5.52 EPS for the current fiscal year.

Clorox Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be given a dividend of $1.20 per share. This represents a $4.80 dividend on an annualized basis and a yield of 3.28%. The ex-dividend date of this dividend is Tuesday, April 23rd. Clorox’s dividend payout ratio (DPR) is presently 761.92%.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the stock. abrdn plc raised its position in shares of Clorox by 20.1% in the 4th quarter. abrdn plc now owns 198,250 shares of the company’s stock worth $28,268,000 after acquiring an additional 33,135 shares in the last quarter. International Assets Investment Management LLC raised its position in shares of Clorox by 17,658.5% in the 4th quarter. International Assets Investment Management LLC now owns 484,453 shares of the company’s stock worth $69,078,000 after acquiring an additional 481,725 shares in the last quarter. Adage Capital Partners GP L.L.C. bought a new position in shares of Clorox in the 3rd quarter worth $6,605,000. Eagle Rock Investment Company LLC bought a new position in shares of Clorox in the 4th quarter worth $2,940,000. Finally, Nordea Investment Management AB raised its position in shares of Clorox by 4.0% in the 4th quarter. Nordea Investment Management AB now owns 9,551 shares of the company’s stock worth $1,362,000 after acquiring an additional 364 shares in the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Company Profile

(Get Free Report

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.